Clinical Trials on Perihilar Cholangiocarcinoma in Belgium
Total 24 results
-
University Hospital, GhentCompletedLocally Advanced and Unresectable, But Non-metastatic Pancreatic Adenocarcinoma or CholangiocarcinomaBelgium
-
American University of Beirut Medical CenterBristol-Myers SquibbTerminatedCholangiocarcinomaLebanon, Belgium, Luxembourg
-
Erasmus Medical CenterRecruitingAdenocarcinoma | Cholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Hilar Cholangiocarcinoma | Common Bile Duct NeoplasmsNetherlands, Belgium
-
Sirtex MedicalCompletedIntrahepatic CholangiocarcinomaFrance, United Kingdom, Belgium, Australia, Spain, United States, Italy, Netherlands
-
Genoscience PharmaTerminatedHepatocellular Carcinoma | Cholangiocarcinoma, IntrahepaticFrance, United States, Belgium
-
Incyte CorporationRecruitingMetastatic Cholangiocarcinoma | Unresectable CholangiocarcinomaUnited States, Canada, Belgium, France, Germany, Italy, China, Spain, Japan, United Kingdom, Netherlands, Switzerland, Austria, Denmark, Finland, Ireland, Israel, Norway, Sweden
-
Erasme University HospitalUnknown
-
MedivirActive, not recruitingHepatocellular Carcinoma | Intrahepatic Cholangiocarcinoma | Liver MetastasesKorea, Republic of, Spain, Belgium, United Kingdom
-
Basilea PharmaceuticaCompletedIntrahepatic Cholangiocarcinoma | Combined Hepatocellular and CholangiocarcinomaCanada, United States, Spain, Belgium, Italy, Korea, Republic of, Germany, Switzerland, France, United Kingdom, Ireland
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaUnited States, Belgium, Germany, Italy, Korea, Republic of, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaKorea, Republic of, United States, Belgium, Spain, Taiwan, China, United Kingdom, France, Canada, Germany, Thailand, Italy, Portugal, Australia, Puerto Rico
-
Taiho Oncology, Inc.Active, not recruitingAdvanced Cholangiocarcinoma | FGFR2 Gene RearrangementsUnited States, Spain, United Kingdom, Australia, Taiwan, Italy, France, Korea, Republic of, Belgium, Japan, Thailand, Germany, Brazil, Peru, Portugal, Argentina, Hong Kong, Mexico, Netherlands, Poland
-
Universitaire Ziekenhuizen KU LeuvenCompletedCholangiocarcinoma | Pancreas Cancer | Obstructive JaundiceBelgium
-
Servier Affaires MédicalesRecruitingCholangiocarcinomaFrance, Netherlands, Spain, Belgium, Sweden, Italy, Australia, Austria, Germany, United Kingdom
-
PCI Biotech ASTerminatedCholangiocarcinomaUnited States, Spain, Belgium, Germany, Italy, Denmark, Finland, France, Korea, Republic of, Norway, Poland, Sweden, Taiwan, Ukraine
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
TransThera Sciences (Nanjing), Inc.RecruitingCholangiocarcinomaKorea, Republic of, United States, Spain, Taiwan, France, Belgium, Germany, Italy, Portugal, United Kingdom, Austria, Poland
-
Incyte CorporationCompletedCholangiocarcinomaUnited States, France, Italy, United Kingdom, Germany, Taiwan, Spain, Belgium, Israel, Korea, Republic of, Japan, Thailand
-
European Organisation for Research and Treatment...TerminatedLiver Cancer | Extrahepatic Bile Duct CancerFrance, United States, Belgium
-
Jules Bordet InstituteEli Lilly and CompanyCompletedCholangiocarcinoma | Endometrial Cancer | Esophageal Adenocarcinoma | Urothelial/Bladder Cancer, Nos | Esophagus SCCFrance, Belgium
-
Universitair Ziekenhuis BrusselKom Op Tegen Kanker; Agentschap voor Innovatie door Wetenschap en Technologie...RecruitingGastric Cancer | Colorectal Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Endometrial Cancer | Urothelial Carcinoma | Biliary Tract Cancer | Locally Advanced Breast Cancer | Cancer of Pancreas | Uterine Cancer | Salivary Gland Cancer | Metastatic Breast Carcinoma | Solid Tumor With Intermediate...Belgium
-
Boehringer IngelheimCompletedGastrointestinal Neoplasms | Pancreatic Neoplasms | CholangiocarcinomaSpain, Belgium, China, United States, Germany, Korea, Republic of, France, Japan
-
Incyte CorporationTerminatedNasopharyngeal Cancer | Esophageal Cancer | Ovarian Cancer | Hepatocellular Carcinoma (HCC) | Cholangiocarcinoma | Solid TumorsUnited States, Belgium
-
Hoffmann-La RocheActive, not recruitingMelanoma | Renal Cell Carcinoma | Adult Solid Tumor | Breast Cancer | Head and Neck Neoplasms | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Neuroendocrine Tumors | Lymphoma, Large-Cell, Anaplastic | Cholangiocarcinoma | Papillary Thyroid Cancer | Sarcomas | Salivary Gland Cancers and other conditionsUnited States, China, Korea, Republic of, Australia, Taiwan, France, Spain, United Kingdom, Hong Kong, Belgium, Italy, Germany, Japan, Singapore, Netherlands, Poland